Directives, methods and suggestions for anti-ulcer drug therapy.
D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000145:classification / Q000627:therapeutic use*; D002229:Carbenoxolone / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*
D000863:Antacids; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D002229:Carbenoxolone